BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32267798)

  • 1. Successful Model for Guideline Implementation to Prevent Cancer-Associated Thrombosis: Venous Thromboembolism Prevention in the Ambulatory Cancer Clinic.
    Holmes CE; Ades S; Gilchrist S; Douce D; Libby K; Rogala B; Parenteau E; Cushman M; Holm AK
    JCO Oncol Pract; 2020 Sep; 16(9):e868-e874. PubMed ID: 32267798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the risk of venous thromboembolism (VTE) in ambulatory patients with cancer: Rationale and implementation of a pharmacist-led VTE risk assessment program in an ambulatory cancer centre.
    Pelletier R
    J Oncol Pharm Pract; 2021 Jun; 27(4):911-918. PubMed ID: 33757321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary prophylaxis of VTE in cancer outpatients.
    Imberti D; Benedetti R
    Thromb Res; 2016 Apr; 140 Suppl 1():S103-8. PubMed ID: 27067962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction and Prevention of Cancer-Associated Thromboembolism.
    Khorana AA; DeSancho MT; Liebman H; Rosovsky R; Connors JM; Zwicker J
    Oncologist; 2021 Jan; 26(1):e2-e7. PubMed ID: 33274815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery.
    Shargall Y; Wiercioch W; Brunelli A; Murthy S; Hofstetter W; Lin J; Li H; Linkins LA; Crowther M; Davis R; Rocco G; Morgano GP; Schünemann F; Muti-Schünemann G; Douketis J; Schünemann HJ; Litle VR
    Eur J Cardiothorac Surg; 2022 Dec; 63(1):. PubMed ID: 36519935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation and validation of a risk stratification method at The Ottawa Hospital to guide thromboprophylaxis in ambulatory cancer patients at intermediate-high risk for venous thrombosis.
    Lustig DB; Rodriguez R; Wells PS
    Thromb Res; 2015 Dec; 136(6):1099-102. PubMed ID: 26260645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Application of Current Proposed Venous Thromboembolism Risk Assessment Model for Ambulatory Patients With Cancer.
    Abdel-Razeq H; Mansour A; Saadeh SS; Abu-Nasser M; Makoseh M; Salam M; Abufara A; Ismael Y; Ibrahim A; Khirfan G; Ibrahim M
    Clin Appl Thromb Hemost; 2018 Apr; 24(3):429-433. PubMed ID: 28183196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery.
    Shargall Y; Wiercioch W; Brunelli A; Murthy S; Hofstetter W; Lin J; Li H; Linkins LA; Crowther M; Davis R; Rocco G; Morgano GP; Schünemann F; Muti-Schünemann G; Douketis J; Schünemann HJ; Litle VR
    J Thorac Cardiovasc Surg; 2023 Mar; 165(3):794-824.e6. PubMed ID: 36895083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External Validation of a Venous Thromboembolic Risk Score for Cancer Outpatients with Solid Tumors: The COMPASS-CAT Venous Thromboembolism Risk Assessment Model.
    Spyropoulos AC; Eldredge JB; Anand LN; Zhang M; Qiu M; Nourabadi S; Rosenberg DJ
    Oncologist; 2020 Jul; 25(7):e1083-e1090. PubMed ID: 32017293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.
    Lyman GH; Khorana AA; Falanga A; Clarke-Pearson D; Flowers C; Jahanzeb M; Kakkar A; Kuderer NM; Levine MN; Liebman H; Mendelson D; Raskob G; Somerfield MR; Thodiyil P; Trent D; Francis CW;
    J Clin Oncol; 2007 Dec; 25(34):5490-505. PubMed ID: 17968019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism prevention in cancer outpatients.
    Khorana AA
    J Natl Compr Canc Netw; 2013 Nov; 11(11):1431-8. PubMed ID: 24225974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer.
    Lyman GH; Carrier M; Ay C; Di Nisio M; Hicks LK; Khorana AA; Leavitt AD; Lee AYY; Macbeth F; Morgan RL; Noble S; Sexton EA; Stenehjem D; Wiercioch W; Kahale LA; Alonso-Coello P
    Blood Adv; 2021 Feb; 5(4):927-974. PubMed ID: 33570602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.
    Kahn SR; Morrison DR; Cohen JM; Emed J; Tagalakis V; Roussin A; Geerts W
    Cochrane Database Syst Rev; 2013 Jul; (7):CD008201. PubMed ID: 23861035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asian venous thromboembolism guidelines: updated recommendations for the prevention of venous thromboembolism.
    Liew NC; Alemany GV; Angchaisuksiri P; Bang SM; Choi G; DE Silva DA; Hong JM; Lee L; Li YJ; Rajamoney GN; Suviraj J; Tan TC; Tse E; Teo LT; Visperas J; Wong RS; Lee LH
    Int Angiol; 2017 Feb; 36(1):1-20. PubMed ID: 27606807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Di Nisio M; Porreca E; Candeloro M; De Tursi M; Russi I; Rutjes AW
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008500. PubMed ID: 27906452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of venous thromboembolism in medical patients and outpatients.
    Stashenko GJ; Tapson VF
    Nat Rev Cardiol; 2009 May; 6(5):356-63. PubMed ID: 19377498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis of venous thromboembolism in cancer patients.
    Frere C; Doucet L; Farge D
    Expert Rev Hematol; 2016 Jun; 9(6):535-9. PubMed ID: 27031534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study.
    Cella CA; Di Minno G; Carlomagno C; Arcopinto M; Cerbone AM; Matano E; Tufano A; Lordick F; De Simone B; Muehlberg KS; Bruzzese D; Attademo L; Arturo C; Sodano M; Moretto R; La Fata E; De Placido S
    Oncologist; 2017 May; 22(5):601-608. PubMed ID: 28424324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing the use of thromboprophylaxis in cancer outpatients in clinical practice: A prospective study.
    Panizo E; Alfonso A; García-Mouriz A; López-Picazo JM; Gil-Bazo I; Hermida J; Páramo JA; Lecumberri R
    Thromb Res; 2015 Dec; 136(6):1145-8. PubMed ID: 26475407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.